Table V.
Adjusted hazard ratios of sleep disorders in patients with prurigo nodularis vs controls, stratified by age and sex
| Subgroup |
Prurigo nodularis vs controls |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outcome | Insomnia |
Sleep apnea |
Restless legs syndrome |
Overall sleep disorder |
||||||||
| aHR | 95% CI | P value | aHR | 95% CI | P value | aHR | 95% CI | P value | aHR | 95% CI | P value | |
| Total | 1.77 | 1.48-2.12 | <.005 | 1.51 | 0.93-2.44 | .10 | 1.54 | 0.92-2.57 | .10 | 1.72 | 1.46-2.02 | <.005 |
| Age, y | ||||||||||||
| <30 | 1.56 | 0.88-2.76 | .13 | 2.34 | 0.31-17.7 | .41 | 1.53 | 0.18-12.6 | .70 | 1.59 | 0.93-2.74 | .09 |
| 30-39 | 2.09 | 1.12-3.91 | .02 | 2.94 | 0.76-11.3 | .12 | 3.48 | 0.14-85.5 | .45 | 2.26 | 1.28-3.98 | <.005 |
| 40-49 | 2.09 | 1.36-3.20 | <.005 | 1.62 | 0.57-4.56 | .36 | 2.70 | 0.44-16.5 | .28 | 2.05 | 1.38-3.05 | <.005 |
| 50-59 | 1.55 | 1.05-2.28 | .03 | 1.36 | 0.58-3.19 | .48 | 2.26 | 0.77-6.60 | .14 | 1.66 | 1.18-2.34 | <.005 |
| 60-69 | 2.08 | 1.36-3.17 | <.005 | 1.05 | 0.31-3.56 | .94 | 0.98 | 0.47-2.07 | .97 | 1.76 | 1.23-2.53 | <.005 |
| 70-79 | 1.20 | 0.76-1.89 | .43 | 0.39 | 0.04-4.42 | .45 | 1.88 | 0.56-6.31 | .31 | 1.17 | 0.77-1.80 | .46 |
| ≥80 | 2.67 | 1.34-5.41 | .01 | 1.05 | 0.07-16.1 | .97 | 0.65 | 0.08-5.09 | .68 | 2.39 | 1.25-4.57 | .01 |
| Sex | ||||||||||||
| Male | 1.74 | 1.30-2.32 | <.005 | 1.43 | 0.76-2.68 | .27 | 1.36 | 0.55-3.37 | .51 | 1.66 | 1.28-2.14 | <.005 |
| Female | 1.79 | 1.42-2.26 | <.005 | 1.37 | 0.64-2.92 | .42 | 1.69 | 0.90-3.16 | .10 | 1.76 | 1.42-2.17 | <.005 |
Bold values denote statistical significance at the P < .05 level.
aHR, Adjusted hazard ratio.